Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 2.23% is 59% below its 5-year average of 5.49%, near the low end of its 5-year range (2.23%–9.60%).
11.68% below its 12-month average of 2.52%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
2.23%
RETURN ON ASSETS (ROA) AVG TTM
2.52%
RETURN ON ASSETS (ROA) AVG 3Y
4.20%
RETURN ON ASSETS (ROA) AVG 5Y
5.49%
RETURN ON ASSETS (ROA) AVG 10Y
5.96%
RETURN ON ASSETS (ROA) AVG 15Y
6.09%
RETURN ON ASSETS (ROA) AVG 20Y
5.97%
CURRENT VS TTM AVG
-11.68%
CURRENT VS 3Y AVG
-46.84%
CURRENT VS 5Y AVG
-59.37%
CURRENT VS 10Y AVG
-62.56%
CURRENT VS 15Y AVG
-63.36%
CURRENT VS 20Y AVG
-62.68%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-56.61%
vs the sector median at left
Market Cap
$49.35B
Return on Assets (ROA)
1.85%
TTM Avg
3.00%
3Y Avg
3.04%
5Y Avg
2.95%
Market Cap
$49.93B
Return on Assets (ROA)
7.25%
TTM Avg
19.91%
3Y Avg
18.29%
5Y Avg
17.04%
Market Cap
$42.81B
Return on Assets (ROA)
1.77%
TTM Avg
-0.35%
3Y Avg
-1.89%
5Y Avg
-2.43%
Market Cap
$42.67B
Return on Assets (ROA)
4.60%
TTM Avg
4.82%
3Y Avg
4.76%
5Y Avg
4.01%
Market Cap
$41.48B
Return on Assets (ROA)
10.31%
TTM Avg
10.56%
3Y Avg
11.14%
5Y Avg
10.55%
Market Cap
$55.68B
Return on Assets (ROA)
-28.75%
TTM Avg
-24.02%
3Y Avg
-10.32%
5Y Avg
-0.33%
Market Cap
$41.04B
Return on Assets (ROA)
33.11%
TTM Avg
29.29%
3Y Avg
27.30%
5Y Avg
27.52%
Market Cap
$56.32B
Return on Assets (ROA)
2.99%
TTM Avg
2.96%
3Y Avg
2.15%
5Y Avg
1.30%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Humana Inc. (HUM) | $48.40B | 2.23% | 2.52% | 4.20% | 5.49% |
| Becton, Dickinson and Company (BDX)vs › | $49.35B | 1.85% | 3.00% | 3.04% | 2.95% |
| Edwards Lifesciences Corporation (EW)vs › | $49.93B | 7.25% | 19.91% | 18.29% | 17.04% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $42.81B | 1.77% | -0.35% | -1.89% | -2.43% |
| IQVIA Holdings Inc. (IQV)vs › | $42.67B | 4.60% | 4.82% | 4.76% | 4.01% |
| Agilent Technologies, Inc. (A)vs › | $41.48B | 10.31% | 10.56% | 11.14% | 10.55% |
| Moderna, Inc. (MRNA)vs › | $55.68B | -28.75% | -24.02% | -10.32% | -0.33% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $41.04B | 33.11% | 29.29% | 27.30% | 27.52% |
| Cardinal Health, Inc. (CAH)vs › | $56.32B | 2.99% | 2.96% | 2.15% | 1.30% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $34.80B | 14.54% | -0.12% | -10.91% | -15.37% |
ROA
2.2%
ROE
6.7%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 2.44% |
| 2024-12-31 | 2.61% |
| 2023-12-31 | 5.31% |
| 2022-12-31 | 6.42% |
| 2021-12-31 | 6.55% |
| 2020-12-31 | 9.60% |
| 2019-12-31 | 9.32% |
| 2018-12-31 | 6.64% |
| 2017-12-31 | 9.17% |
| 2016-12-31 | 2.38% |
| 2015-12-31 | 5.08% |
| 2014-12-31 | 4.89% |
| 2013-12-31 | 5.93% |
| 2012-12-31 | 6.26% |
| 2011-12-31 | 7.95% |
| 2010-12-31 | 6.84% |
| 2009-12-31 | 7.35% |
| 2008-12-31 | 4.96% |
| 2007-12-31 | 6.47% |
| 2006-12-31 | 4.81% |
| 2005-12-31 | 4.49% |
| 2004-12-31 | 4.95% |
| 2003-12-31 | 4.23% |
| 2002-12-31 | 3.10% |
| 2001-12-31 | 2.66% |
| 2000-12-31 | 2.16% |
| 1999-12-31 | -7.80% |
| 1998-12-31 | 2.35% |
| 1997-12-31 | 3.19% |
| 1996-12-31 | 0.38% |
